COVID-KOSHA
Home
Help
(current)
Comment
!
Note: Language translations may be imperfect
A model anti-pandemic portal for scientists & public
High priority articles (R1, Most articles most likely to be relevant):
Second priority articles (R2, Moderate portion of articles likely to be relevant):
Other articles (R3, Lesser portion of articles likely to be relevant):
Drug Studies-in vitro
Last updated: 2025 Jun 18
Total hit(s): 1252
S.No.
PMID
Ascending order
Descending order
Title
Ascending order
Descending order
Journal Name
Ascending order
Descending order
Publish Date
Ascending order
Descending order
Impact Factor
Ascending order
Descending order
Citations
Ascending order
Descending order
Auto summary
Ascending order
Descending order
1
40077853
Characterization of the binding features between SARS-CoV-2 5'-proximal transcripts of genomic RNA and nucleocapsid proteins.
RNA Biol
2025 Dec
1
2
40252899
Discovery of cinnamoyl-flavonoid hybrid derivatives as inhibitors of SARS-CoV-2 M(pro) and anti-inflammatory agents: Experimental and in silico insights into their efficacy against lipopolysaccharide-induced lung injury.
Eur J Pharmacol
2025 Jul 5
3.24
1
3
40459233
Functional and structural characterization of treatment-emergent nirmatrelvir resistance mutations at low frequencies in the main protease (Mpro) reveals a unique evolutionary route for SARS-CoV-2 to gain resistance.
J Infect Dis
2025 Jun 3
4.73
1
4
40503916
GSDMD and GSDME exhibit distinct roles in enteric coronavirus PDCoV-induced pyroptosis and inflammatory responses.
J Virol
2025 Jun 12
4.16
1
5
40498855
Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primates.
Sci Transl Med
2025 Jun 11
11.64
1
6
40254136
Lipid nanoparticles target neutrophils to reduce SARS-CoV-2-induced lung injury and inflammation.
J Control Release
2025 Jun 10
15.5
1
7
40160515
In silico studies to understand the interactions of flavonoid inhibitor with nsp12-RNA dependent RNA polymerase of SARS-CoV-2 and its homologs.
Biochem Biophys Rep
2025 Jun
1.65
1
8
40442985
Pathological Glucose Levels Enhance Entry Factor Expression and Hepatic SARS-CoV-2 Infection.
J Cell Mol Med
2025 Jun
4.59
1
9
40401447
The Combination of TLR4 and TLR9 Agonists with Self-Amplifying RNA Lipid Nanoparticles Leads to a More Powerful Immune Response Against SARS-CoV-2.
Viral Immunol
2025 Jun
3.4
1
10
40255103
Anti-SARS-CoV-2 Small Molecule Targeting of Oxysterol-Binding Protein (OSBP) Activates Cellular Antiviral Innate Immunity.
ACS Infect Dis
2025 May 9
4.96
1
11
40349960
Palmitoylated COX-2(Cys555) reprogrammed mitochondrial metabolism in pyroptotic inflammatory injury in patients with post-acute COVID-19 syndrome.
J Adv Res
2025 May 9
1
12
40335518
Exploring the therapeutic potential of Thymus vulgaris ethanol extract: a computational screening for antimicrobial compounds against COVID-19 induced mucormycosis.
Sci Rep
2025 May 7
4.12
1
13
40343305
Synthesis, molecular docking, and in vitro activity of a novel angiotensin-converting enzyme 2 inhibitor, LMS1007: a potential molecule in Covid-19 and cancer treatments.
RSC Adv
2025 May 6
1
14
40322961
Structure-Activity Relationships of New 1-Aryl-1H-indole Derivatives as SARS-CoV-2 Nsp13 Inhibitors.
ChemMedChem
2025 May 5
5.5
1
15
40407038
ELV-N34, RvD6-Isomer, or NPD1 Halt Replication of SARS-CoV-2 Omicron BA.5 Virus in Human Lung and Nasal Cells.
FASEB J
2025 May 31
4.17
1
16
40447603
Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base.
Nat Commun
2025 May 30
11.8
1
17
40441028
Tipranavir analogs as antiviral agents: Design, synthesis, in vitro, and in silico study of new SARS-CoV-2 main protease inhibitors.
Bioorg Chem
2025 May 23
3.94
1
18
40404955
Comparable immune escape capacity between KP.2 and other SARS-CoV-2 variants in the central Chinese population after the first COVID-19 booster.
Sci Rep
2025 May 22
4.12
1
19
40399563
Inflammatory metabolite 7alpha,25-OHC promotes TIMP1 expression in COVID-19 monocytes through synergy effect of SMARCC1/JUND/H3K27ac.
Cell Mol Life Sci
2025 May 21
7.03
1
20
40392435
A case of autosomal dominant polycystic kidney disease with systemic lupus erythematosus developing after SARS-CoV-2 vaccination.
CEN Case Rep
2025 May 20
1.5
1
21
40379909
Formulation and In-Vitro Testing of Nebulized Camostat Mesylate Loaded Nanoliposomes for the Treatment of SARS-CoV- 2 Infection.
AAPS PharmSciTech
2025 May 16
2.451
1
22
40372136
NMR Structural Characterization of SARS-CoV-2 ORF6 Reveals an N-Terminal Membrane Anchor.
J Am Chem Soc
2025 May 15
25
1
23
40360482
SARS-CoV-2 virus lacking the envelope and membrane open-reading frames as a vaccine platform.
Nat Commun
2025 May 14
11.8
1
24
40365983
Can Labs Help With Vaccination? In Vitro Tests in Diagnosis of Allergy to COVID-19 Vaccines-A Systematic Review.
Immun Inflamm Dis
2025 May
2.28
1
25
40183251
Rice-derived SARS-CoV-2 glycoprotein S1 subunit vaccine elicits humoral and cellular immune responses.
Plant Biotechnol J
2025 Apr 4
1